Tilray Brands (TLRY) Capital Expenditures (2017 - 2025)
Tilray Brands' (TLRY) quarterly Capital Expenditures came in at $6.3 million in Q2 2025, down 34.8% YoY from $9.7 million in Q2 2024, and down 56.08% on a QoQ basis from $14.4 million in Q1 2025.
Tilray Brands (TLRY) Capital Expenditures (2017 - 2025) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Capital Expenditures data on file, last reported at $6.3 million in Q2 2025.
- Quarterly Capital Expenditures fell 34.8% year-over-year to $6.3 million in Q2 2025, while the trailing twelve-month figure through May 2025 was $32.9 million (up 12.54% YoY) and the FY2025 annual result came in at $32.9 million, up 12.54% from the prior year.
- Capital Expenditures retreated to $6.3 million in Q2 2025, from $14.4 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $16.3 million in Q3 2021 to a low of $857000.0 in Q1 2023.
- A 5-year average of $7.2 million and a median of $5.9 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2021 — Capital Expenditures slumped 89.78% — and 2024, when it soared 1011.79%.
- Tracing TLRY's Capital Expenditures over 5 years: stood at $7.5 million in 2021, then sank by 39.83% to $4.5 million in 2022, then grew by 29.14% to $5.9 million in 2023, then dropped by 7.22% to $5.4 million in 2024, then grew by 16.46% to $6.3 million in 2025.
- The last three Capital Expenditures figures came in at $6.3 million (Q2 2025), $14.4 million (Q1 2025), and $5.4 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 519.72 Mn | 285.09 Mn | 90.52 Mn | 10.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 6.33 Mn |
| May 31, 2025 | 6.33 Mn |
| Feb 28, 2025 | 14.41 Mn |
| Feb 28, 2025 | 14.41 Mn |
| Nov 30, 2024 | 5.44 Mn |
| Nov 30, 2024 | 5.44 Mn |
| Aug 31, 2024 | 6.74 Mn |
| Aug 31, 2024 | 6.74 Mn |
| May 31, 2024 | 9.71 Mn |
| May 31, 2024 | 9.71 Mn |
| Feb 29, 2024 | 9.53 Mn |
| Feb 29, 2024 | 9.53 Mn |
| Nov 30, 2023 | 5.86 Mn |
| Nov 30, 2023 | 5.86 Mn |
| Aug 31, 2023 | 4.15 Mn |
| Aug 31, 2023 | 4.15 Mn |
| May 31, 2023 | 12.41 Mn |
| May 31, 2023 | 12.41 Mn |
| Feb 28, 2023 | 857,000.00 |
| Feb 28, 2023 | 857,000.00 |